Stock listing

NASDAQ:PSNL Personalis, Inc. Stock

Home listing (NASDAQ) of Personalis, Inc.

Follow Personalis, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:PSNL

$14.27 USD -0.71 (-4.7%)

Close on Nov 20, 2026

Past year +72.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$14.23 – $14.67 USDNov 20, 2026
Volume
3.34M sharesNov 20, 2026
Market cap
$1.55B USDAt the close on Nov 20, 2026 · price × 108.4M shares outstanding
52-week range
$4.96 – $18.89 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$44.63M USDMedian day 2.32M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Personalis, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PSNL · Home$14.27 USD-0.71 (-4.7%)3,335,328$14.55$14.67$14.23$14.98Close on Nov 20, 2026
Frankfurt:04X€13.22 EUR-0.71 (-5.1%)190€13.07€13.22€13.07€13.93Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PSNL · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$14.27-0.71-4.7%$14.55$14.67$14.233,335,328
$14.98+0.18+1.2%$14.73$15.08$14.701,466,535
$14.800.000.0%$14.81$15.02$14.523,134,964
$14.80-0.91-5.8%$15.60$15.69$14.786,272,680
$15.71-0.15-0.9%$15.90$15.94$15.582,803,799
$15.86-0.10-0.6%$15.90$15.95$15.811,864,808
$15.96+0.08+0.5%$15.90$16.04$15.901,139,009
$15.88-0.07-0.4%$15.88$16.07$15.811,755,224
$15.95+0.16+1.0%$15.80$16.00$15.802,323,917
$15.79+0.24+1.5%$15.55$15.81$15.553,000,168
$15.55-0.24-1.5%$15.76$15.85$15.523,788,256
$15.79+0.04+0.3%$15.85$15.91$15.692,217,742
$15.75-0.01-0.1%$15.90$15.97$15.752,930,166
$15.76-0.06-0.4%$15.92$15.93$15.752,202,758
$15.82-0.105-0.7%$15.84$15.91$15.652,364,402
$15.93-0.075-0.5%$15.98$16.05$15.88749,165
$16.00+0.02+0.1%$15.93$16.11$15.861,228,822
$15.98+0.10+0.6%$15.86$16.13$15.801,829,253
$15.88+0.03+0.2%$15.81$15.99$15.771,140,587
$15.85+0.03+0.2%$15.73$15.89$15.671,115,900
$15.82-0.08-0.5%$15.90$15.96$15.632,694,800
$15.90-0.04-0.3%$15.76$16.12$15.762,791,300
$15.94+0.06+0.4%$15.94$16.00$15.852,380,300
$15.88+0.23+1.5%$15.83$16.02$15.753,155,600
$15.65-0.28-1.8%$15.86$16.00$15.513,305,800
$15.93+0.03+0.2%$15.88$16.08$15.832,141,000
$15.90+0.05+0.3%$15.71$16.00$15.683,262,400
$15.85+0.05+0.3%$15.82$15.97$15.793,817,200
$15.80-0.20-1.2%$16.01$16.17$15.802,254,300
$16.00-0.06-0.4%$16.19$16.24$15.981,835,900
$16.06+0.06+0.4%$15.92$16.20$15.921,467,500
$16.00-0.03-0.2%$15.78$16.10$15.683,817,900
$16.03-0.37-2.3%$16.25$16.58$15.845,659,800
$16.40+0.12+0.7%$16.12$16.47$16.021,702,500
$16.28+0.11+0.7%$16.38$16.44$16.121,139,100
$16.17-0.11-0.7%$16.22$16.32$16.071,659,800
$16.28-0.07-0.4%$16.42$16.59$16.26981,400
$16.35+0.03+0.2%$16.25$16.47$16.081,037,800
$16.32-0.14-0.9%$16.22$16.48$16.001,669,500
$16.46-0.11-0.7%$16.74$16.77$16.381,014,000
$16.57+0.22+1.3%$16.16$16.63$16.101,705,800
$16.35-0.01-0.1%$16.16$16.42$16.091,123,800
$16.36+0.12+0.7%$16.29$16.48$16.131,369,300
$16.24-0.16-1.0%$16.38$16.50$16.071,816,200
$16.40+0.17+1.0%$16.30$16.44$16.123,180,400
$16.23+0.12+0.7%$16.42$16.45$16.135,649,400
$16.11+0.01+0.1%$16.20$16.39$15.962,255,900
$16.10-0.19-1.2%$16.15$16.40$15.922,426,600
$16.29+0.08+0.5%$16.15$16.40$16.051,690,100
$16.21-0.12-0.7%$16.46$16.58$16.191,407,000
$16.33-0.07-0.4%$16.07$16.49$16.002,296,700
$16.40-0.20-1.2%$16.60$16.83$16.382,782,900
$16.60-0.60-3.5%$17.20$17.35$16.462,548,500
$17.20+0.37+2.2%$16.67$17.23$16.522,522,200
$16.83+0.10+0.6%$16.95$17.00$16.442,492,800
$16.73-0.33-1.9%$17.14$17.16$16.712,225,500
$17.06+0.28+1.7%$17.00$17.38$16.813,618,900
$16.78-0.29-1.7%$17.00$17.24$16.602,845,900
$17.07+0.27+1.6%$16.75$17.24$16.602,973,200
$16.80-0.28-1.6%$17.08$17.64$16.554,943,700
$17.08-0.17-1.0%$17.18$17.50$16.842,174,600
$17.25+0.19+1.1%$17.09$17.48$16.802,897,036
$17.06-1.32-7.2%$17.01$17.43$16.794,793,048
$18.38+1.50+8.9%$16.66$18.89$16.627,996,300
$16.88+1.07+6.8%$15.91$17.06$15.9114,208,500
Ticker
NASDAQ:PSNL
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Personalis Reports Third Quarter Results

Nov 4, 2026

Closed $15.55 (-1.5%) on Nov 5, 2026

All Personalis, Inc. news

Personalis, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
28 in the last 12 months · 221 in all · newest Nov 4, 2026 · oldest 2019
Calls
18 calls with a replay · 18 with a transcript · latest May 7, 2026
Decks
6 decks · latest Nov 12, 2026

Where Personalis, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:PSNL · Home listing · This pageNASDAQUnited StatesUSD
Tradegate:04XTradegateGermanyEUR
gettex:04XgettexGermanyEUR
Lang & Schwarz:A2PLTKLang & SchwarzGermanyEUR
LS Exchange:A2PLTKLS ExchangeGermanyEUR
BOATS:PSNLBOATSUnited StatesUSD
Frankfurt:04XFrankfurtGermanyEUR
Dusseldorf:04XDusseldorfGermanyEUR
Hamburg:04XHamburgGermanyEUR
Munich:04XMunichGermanyEUR
Stuttgart:04XStuttgartGermanyEUR
Hanover:04XHanoverGermanyEUR
Xetra:04XXetraGermanyEUR

Valuation

EV/sales 17.3× against a median of 4.0×: 10th lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.39B USD
P/E
Loss
EV/sales
17.3×
EV/EBITDA
Negative EBITDA
Price/book
7.3×
Gross margin
16.7%
Operating margin
−156.7%
Net margin
−147.7%
Debt to equity
0.2×
Beta vs S&P 500
2.03

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Personalis, Inc. · NASDAQ:PSNLUS$1.55BUS$1.39Bn/a17.3×n/a7.3×−147.7%0.2×2.03
Alamar Biosciences, Inc. · NASDAQ:ALMRUS$1.84BUS$1.66Bn/a14.5×n/a6.1×−48.2%0.1×1.70
Fortrea Holdings Inc. · NASDAQ:FTREUS$1.79BUS$2.62Bn/a1.0×28.7×3.4×−2.6%2.0×1.68
ChemoMetec A/S · OMXCOP:CHEMMUS$1.72BUS$1.68B58.0×22.3×40.6×16.1×39.5%0.0×n/a
GemPharmatech Co., Ltd. Class A · SSE:688046US$1.65BUS$1.49B54.4×10.5×n/a4.7×21.5%0.0×n/a
PolyPeptide Group AG · SIX:PPGNUS$1.62BUS$1.71Bn/a4.0×34.2×4.2×−5.4%0.4×n/a
Sino Biological Inc. Class A · SZSE:301047US$1.45BUS$1.01B54.1×8.5×n/a1.9×22.6%0.0×n/a
Qingdao Haier Biomedical Co., Ltd. Class A · SSE:688139US$1.41BUS$1.16B34.7×3.1×n/a2.1×10.8%0.0×n/a
Nanjing Vazyme Biotech Co., Ltd. Class A · SSE:688105US$1.38BUS$960.3M14,463×4.1×n/a2.5×0.0%0.0×n/a
GeneDx Holdings Corp. · NASDAQ:WGSUS$1.36BUS$1.34Bn/a2.9×n/a5.6×−24.1%0.6×1.73
PharmaBlock Sciences (Nanjing), Inc. Class A · SZSE:300725US$1.29BUS$1.08B38.9×3.3×n/a1.9×10.1%0.0×n/a
Median of the othersUS$1.53BUS$1.41B54.2×4.0×34.2×3.8×5.1%0.0×1.70

Forecasts

1 strong buy · 4 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
15.17 USD · Analysts' mean
EPS, year to Dec 2026
-1.16 · 2 analysts
Revenue, year to Dec 2026
88.65M · 2 analysts

Team and board

Officers

OfficerRole
Aaron TachibanaChief Financial Officer and Chief Operating Officer
Richard ChenPresident and Chief Medical Officer
Stephen MooreSenior Vice President, Chief Legal Officer
Caroline CornerInvestor Relations
Ashish KheterpalSenior Vice President, Chief Information Officer
Christian HaudenschildSenior Vice President, Genomic Science
Deepshikha BhandariSenior Vice President, Regulatory, Quality & Clinical Compliance
Stephane MouradianSenior Vice President, Business Development

Board

DirectorRole
Karin EasthamChair
A. Blaine BowmanDirector
Christopher HallDirector
Kenneth J. WidderDirector
Lonnie ShoffDirector
Olivia BloomDirector
Woodrow A. MyersDirector

Events

Calls

CallWhenStatus
Personalis (NASDAQ:PSNL) Q1 2026 Earnings CallThu, May 07, 2026 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q3 2025 Earnings CallTue, Nov 04, 2025 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q1 2025 Earnings CallTue, May 06, 2025 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q4 2024 Earnings CallThu, Feb 27, 2025 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q3 2024 Earnings CallWed, Nov 06, 2024 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q2 2024 Earnings CallWed, Aug 07, 2024 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q1 2024 Earnings CallWed, May 08, 2024 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q4 2023 Earnings CallWed, Feb 28, 2024 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q3 2023 Earnings CallTue, Nov 07, 2023 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q2 2023 Earnings CallTue, Aug 08, 2023 · 5:00 PM ETReplay
All 18 calls
CallWhenStatus
Personalis (NASDAQ:PSNL) Q1 2023 Earnings CallWed, May 03, 2023 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q4 2022 Earnings CallThu, Feb 23, 2023 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q3 2022 Earnings CallWed, Nov 02, 2022 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q2 2022 Earnings CallWed, Aug 03, 2022 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q1 2022 Earnings CallWed, May 04, 2022 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q4 2021 Earnings CallThu, Feb 24, 2022 · 5:00 PM ETReplay
Personalis (NASDAQ:PSNL) Q3 2021 Earnings CallThu, Nov 04, 2021 · 8:30 AM ETReplay
Personalis (NASDAQ:PSNL) Q1 2021 Earnings CallWed, May 05, 2021 · 5:00 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 4, 2026 · After close−1.5%
Q2 2026Aug 4, 2026 · After close0.0%
Q1 2026May 7, 2026 · After close−0.2%
Q4 2025Feb 26, 2026+9.0%
Q3 2025Nov 4, 2025 · After close−12.3%
Q2 2025Aug 5, 2025 · After close−21.9%
Q1 2025May 6, 2025 · After close+21.0%
Q4 2024Feb 26, 2025 · After close−5.4%
Q3 2024Nov 6, 2024 · After close−22.6%
Q2 2024Aug 7, 2024 · After close+19.1%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close+5.4%
Q4 2023Feb 28, 2024 · After close+6.2%
Q3 2023Nov 7, 2023 · After close+21.5%
Q2 2023Aug 8, 2023 · After close+0.5%
Q1 2023May 3, 2023 · After close−5.0%
Q4 2022Feb 23, 2023 · After close−7.2%
Q3 2022Nov 2, 2022 · After close0.0%
Q2 2022Aug 3, 2022 · After close+0.5%
Q1 2022May 4, 2022 · After close−9.9%
Q4 2021Feb 24, 2022 · After close+2.4%

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (November 2026)Merger or acquisition30 slidesNov 12, 2026
Merger or Acquisition (October 2026)Merger or acquisition5 slidesOct 21, 2026
Investor Presentation (August 2026)Investor deck17 slidesAugust 2026
Merger or Acquisition (July 2026)Merger or acquisition11 slidesJul 20, 2026
Q1 2025 Earnings PresentationEarnings20 slidesMay 6, 2025
ESMO Congress 2023Conference15 slidesOct 21, 2023

Open Decks

Financings

RaiseDate
At-the-market programme of common stock
Tranche closed: US$17.8M raised · US$5.89 a share
May 6, 2025
Strategic investment of common stock
Announced: US$50M · US$3.56 a share
Buyers: Merck ($50 million of common stock; approximately 14 million shares, approximately 16.5 percent beneficial ownership following closing)
Dec 19, 2024

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$17.00 a share on Jun 19, 2019.

Price
US$17.00 a share
Shares offered
7,921,500 shares of common stock
Offering size
US$134.7 million
Underwriters' option
Up to 1,188,225 more shares
Underwriters
MORGAN STANLEY, BofA MERRILL LYNCH, COWEN, OPPENHEIMER & CO. · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceMar 27, 2019
Filed publiclyMay 23, 2019
Amended onceJun 7, 2019
Shares registered with an exchangeJun 17, 2019
Declared effective by the SECJun 19, 2019
Final prospectus, with the priceJun 20, 2019

Open IPO · From the cover of the final prospectus (424B4) filed Jun 20, 2019

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue69.6M84.6M73.5M65.0M85.5M78.6M65.2M37.8M9.39M
Cost of revenue53.9M57.8M55.3M51.7M53.8M58.5M43.1M26.0M11.7M
Gross profit15.8M26.8M18.2M13.3M31.7M20.1M22.1M11.8M-2.34M
Research and development50.3M48.9M64.8M64.9M49.3M28.6M22.4M14.3M9.92M
Selling, general and administrative53.6M46.2M49.7M64.0M47.7M33.7M22.1M11.3M9.90M
Operating income-88.1M-68.3M-109.9M-115.5M-65.4M-42.1M-22.4M-13.8M-22.2M
Depreciation and amortization10.0M10.9M11.3M8.43M6.01M5.76M4.75M3.07M1.22M
EBITDA-78.0M-57.3M-98.6M-107.1M-59.3M-36.4M-17.7M-10.7M-20.9M
Interest expense205.0K24.0K110.0K201.0K184.0K2.00K1.13M1.89M1.30M
Income before tax-81.2M-81.3M-108.2M-113.3M-65.2M-41.2M-25.1M-19.9M-23.6M
Income tax21.0K18.0K83.0K40.0K14.0K57.0K9.00K7.00K5.00K
Net income-81.3M-81.3M-108.3M-113.3M-65.2M-41.3M-25.1M-19.9M-23.6M
Earnings per share, basic-0.91-1.37-2.25-2.48-1.49-1.20-1.39-6.49-7.78
Earnings per share, diluted-0.91-1.37-2.25-2.48-1.49-1.20-1.39-6.49-7.78

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents124.2M91.4M57.0M89.1M105.6M68.5M55.0M19.7M22.6M
Short-term investments115.7M93.6M57.2M78.5M181.5M134.8M73.2M00
Receivables16.2M8.14M17.7M16.6M18.5M6.35M3.30M4.46M1.94M
Inventory6.14M3.98M5.66M6.38M4.08M2.67M1.42M2.13M822.0K
Current assets268.0M203.0M146.7M199.7M318.2M220.7M139.6M29.6M26.7M
Property, plant and equipment44.8M48.3M57.4M61.9M19.6M11.8M14.1M11.5M6.34M
Goodwill00
Total assets334.2M270.3M225.1M292.7M396.5M244.8M157.3M41.7M33.6M
Accounts payable13.0M6.40M14.9M12.9M9.22M8.30M7.34M6.57M4.04M
Current liabilities39.6M31.1M47.2M33.1M31.3M40.6M50.0M57.9M49.0M
Long-term debt683.0K292.0K
Total debt39.9M44.2M47.7M48.6M58.3M005.00M17.8M
Total liabilities73.0M67.3M95.7M74.6M86.2M49.9M50.6M58.7M126.2M
Shareholders' equity261.2M203.0M129.4M218.1M310.3M194.9M106.7M-106.4M-92.6M
Shares outstanding102.5M85.2M50.5M46.7M44.9M39.1M31.2M3.09M43.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-74.9M-45.1M-56.3M-70.2M-70.8M-42.7M-18.1M5.57M290.0K
Capital spending-4.50M-1.60M-10.9M-49.9M-11.1M-3.25M-8.38M-7.85M-5.16M
Free cash flow-79.5M-46.8M-67.2M-120.1M-81.9M-45.9M-26.5M-2.28M-4.87M
Cash from investing-22.6M-35.1M13.1M52.5M-60.1M-65.1M-81.6M-7.85M-5.16M
Cash from financing130.3M114.7M11.0M1.37M169.7M121.3M134.9M-591.0K16.4M
Dividends paid00
Share buybacks2.46M166.4M121.3M145.4M76.0K65.0K
Change in cash32.8M34.4M-32.1M-16.5M38.9M13.5M35.3M-2.87M11.5M

Open Financials

Filings

FilingDateTypeFiled with
425Nov 16, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2026Big-stake noticeSEC
425Nov 12, 2026Other filingsSEC
425Nov 6, 2026Other filingsSEC
4 · Change in ownershipNov 4, 2026Insider tradeSEC
10-Q · Quarterly reportNov 4, 2026Quarterly reportSEC
8-K · Current reportNov 4, 2026ResultsSEC
425Nov 3, 2026Other filingsSEC
425Oct 30, 2026Other filingsSEC
Show 200 filings
FilingDateTypeFiled with
DEFM14AOct 21, 2026Meeting noticeSEC
425Oct 20, 2026Other filingsSEC
425Oct 20, 2026Other filingsSEC
SC 13E3/AOct 20, 2026Other filingsSEC
425Oct 6, 2026Other filingsSEC
8-K · Current reportOct 6, 2026Current reportSEC
SC 13E3/AOct 2, 2026Other filingsSEC
CT ORDEROct 2, 2026Other filingsSEC
4 · Change in ownershipSep 22, 2026Insider tradeSEC
4 · Change in ownershipSep 22, 2026Insider tradeSEC
4 · Change in ownershipSep 22, 2026Insider tradeSEC
4 · Change in ownershipSep 22, 2026Insider tradeSEC
425Sep 15, 2026Other filingsSEC
SC 13E3Aug 31, 2026Other filingsSEC
8-K · Current reportAug 20, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 4, 2026Quarterly reportSEC
8-K · Current reportAug 4, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeJul 29, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 21, 2026Big-stake noticeSEC
425Jul 20, 2026Other filingsSEC
8-K · Current reportJul 20, 2026Material contractSEC
425Jul 20, 2026Other filingsSEC
425Jul 20, 2026Other filingsSEC
425Jul 20, 2026Other filingsSEC
425Jul 20, 2026Other filingsSEC
425Jul 20, 2026Other filingsSEC
8-K · Current reportJul 20, 2026ResultsSEC
4 · Change in ownershipJul 15, 2026Insider tradeSEC
144 · Notice of proposed saleJul 15, 2026Other filingsSEC
4 · Change in ownershipJul 9, 2026Insider tradeSEC
144 · Notice of proposed saleJul 9, 2026Other filingsSEC
4 · Change in ownershipJun 29, 2026Insider tradeSEC
144 · Notice of proposed saleJun 29, 2026Other filingsSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
144 · Notice of proposed saleJun 26, 2026Other filingsSEC
144 · Notice of proposed saleJun 26, 2026Other filingsSEC
4/A · Change in ownership, amendedJun 11, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 10, 2026Big-stake noticeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
144 · Notice of proposed saleJun 4, 2026Other filingsSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
144 · Notice of proposed saleMay 29, 2026Other filingsSEC
144 · Notice of proposed saleMay 28, 2026Other filingsSEC
8-K · Current reportMay 20, 2026Current reportSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
8-K · Current reportMay 13, 2026Meeting outcomeSEC
8-K · Current reportMay 13, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeMay 12, 2026Big-stake noticeSEC
S-3ASR · Registration statementMay 7, 2026Offer documentSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 8, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 2, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 2, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 2, 2026Meeting noticeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
8-K · Current reportMar 17, 2026Management or board changeSEC
S-8 · Registration statement for employee plansFeb 26, 2026Offer documentSEC
10-K · Annual reportFeb 26, 2026Annual reportSEC
8-K · Current reportFeb 26, 2026ResultsSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeFeb 17, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 13, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 29, 2026Big-stake noticeSEC
4 · Change in ownershipJan 23, 2026Insider tradeSEC
144 · Notice of proposed saleJan 22, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeJan 8, 2026Big-stake noticeSEC
8-K · Current reportJan 8, 2026ResultsSEC
8-K · Current reportNov 28, 2025Current reportSEC
424B5 · ProspectusNov 28, 2025Offer documentSEC
4 · Change in ownershipNov 28, 2025Insider tradeSEC
144 · Notice of proposed saleNov 25, 2025Other filingsSEC
8-K · Current reportNov 25, 2025Current reportSEC
8-K · Current reportNov 10, 2025Current reportSEC
4 · Change in ownershipNov 5, 2025Insider tradeSEC
10-Q · Quarterly reportNov 4, 2025Quarterly reportSEC
8-K · Current reportNov 4, 2025ResultsSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 12, 2025Big-stake noticeSEC
8-K · Current reportAug 21, 2025Current reportSEC
S-8 · Registration statement for employee plansAug 5, 2025Offer documentSEC
8-K · Current reportAug 5, 2025ResultsSEC
10-Q · Quarterly reportAug 5, 2025Quarterly reportSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
8-K · Current reportJul 9, 2025Material contractSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
8-K · Current reportMay 19, 2025Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 6, 2025Quarterly reportSEC
8-K · Current reportMay 6, 2025ResultsSEC
EFFECT · Notice that a registration is effectiveApr 4, 2025Other filingsSEC
ARS · Annual report to shareholdersApr 3, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 3, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 3, 2025Meeting noticeSEC
CORRESP · Letter to the SECApr 1, 2025Other filingsSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
UPLOAD · Letter from the SECMar 6, 2025Other filingsSEC
S-8 · Registration statement for employee plansFeb 27, 2025Offer documentSEC
S-3 · Registration statementFeb 27, 2025Offer documentSEC
10-K · Annual reportFeb 27, 2025Annual reportSEC
8-K · Current reportFeb 27, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 10, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2025Big-stake noticeSEC
4 · Change in ownershipJan 30, 2025Insider tradeSEC
4 · Change in ownershipJan 30, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 10, 2025Big-stake noticeSEC
8-K · Current reportJan 7, 2025ResultsSEC
8-K · Current reportDec 27, 2024Current reportSEC
424B5 · ProspectusDec 27, 2024Offer documentSEC
SCHEDULE 13G · Big-stake noticeDec 23, 2024Big-stake noticeSEC
3 · Initial statement of ownershipDec 23, 2024Insider tradeSEC
8-K · Current reportDec 19, 2024Material contractSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 8, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 6, 2024Quarterly reportSEC
8-K · Current reportNov 6, 2024ResultsSEC
4 · Change in ownershipNov 5, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedOct 23, 2024Big-stake noticeSEC
8-K · Current reportSep 19, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveSep 12, 2024Other filingsSEC
CORRESP · Letter to the SECSep 9, 2024Other filingsSEC
UPLOAD · Letter from the SECSep 9, 2024Other filingsSEC
S-3 · Registration statementAug 30, 2024Offer documentSEC
SC 13D/A · Big-stake notice, amendedAug 20, 2024Big-stake noticeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedAug 19, 2024Big-stake noticeSEC
8-K · Current reportAug 16, 2024Material contractSEC
10-Q · Quarterly reportAug 7, 2024Quarterly reportSEC
8-K · Current reportAug 7, 2024ResultsSEC
4 · Change in ownershipAug 1, 2024Insider tradeSEC
4 · Change in ownershipAug 1, 2024Insider tradeSEC
SC 13G · Big-stake noticeJul 26, 2024Big-stake noticeSEC
3 · Initial statement of ownershipJul 3, 2024Insider tradeSEC
SC 13D · Big-stake noticeJul 3, 2024Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedJun 28, 2024Big-stake noticeSEC
8-K · Current reportJun 27, 2024Material contractSEC
4 · Change in ownershipJun 20, 2024Insider tradeSEC
4 · Change in ownershipJun 20, 2024Insider tradeSEC
4 · Change in ownershipJun 20, 2024Insider tradeSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
8-K · Current reportMay 21, 2024Meeting outcomeSEC
10-Q · Quarterly reportMay 8, 2024Quarterly reportSEC
8-K · Current reportMay 8, 2024ResultsSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
ARS · Annual report to shareholdersApr 2, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 2, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 2, 2024Meeting noticeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC

This page holds 200 of 560 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Personalis, Inc.’s releases · as of Oct 30, 2026

Common shares
108,403,814
Fully diluted
108,403,814

Fully diluted

LineSharesAs of
Common shares108,403,814Oct 30, 2026

Share count over time

CountShares
Oct 30, 2026108,403,814

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Merck & Co., Inc.14M13.0%US$229MSep 30, 2026
ARK7.12M6.6%US$116MSep 30, 2026
BlackRock6.93M6.4%US$113MSep 30, 2026
Lightspeed Management Company, L.L.C.6.1M5.6%US$99.3MSep 30, 2026
Balyasny Asset Management L.P.4.96M4.6%US$80.7MSep 30, 2026
Vanguard4.47M4.1%US$72.7MSep 30, 2026
abrdn3.48M3.2%US$56.7MSep 30, 2026
Casdin Capital, LLC2.3M2.1%US$37.4MSep 30, 2026
Qube Research & Technologies Ltd2.18M2.0%US$35.6MSep 30, 2026
Kennedy Capital Management LLC2.06M1.9%US$33.6MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Geode Capital1.88M1.7%US$30.6MSep 30, 2026
Nuveen1.59M1.5%US$25.9MSep 30, 2026
State Street1.59M1.5%US$25.9MSep 30, 2026
Glazer Capital, LLC1.36M1.3%US$22.1MSep 30, 2026
Bank of America1.33M1.2%US$21.7MSep 30, 2026
Dimensional1.23M1.1%US$20.1MSep 30, 2026
T. Rowe Price1.18M1.1%US$19.2MSep 30, 2026
Ameriprise1.11M1.0%US$18MSep 30, 2026
Millennium1.11M1.0%US$18MSep 30, 2026
Goldman Sachs1.1M1.0%US$18MSep 30, 2026
Slotnik Capital, LLC932K0.86%US$15.2MSep 30, 2026
Sculptor Capital LP905K0.83%US$14.7MSep 30, 2026
Alpine Associates Management Inc.790K0.73%US$12.9MSep 30, 2026
Schonfeld Strategic Advisors LLC720K0.66%US$11.7MSep 30, 2026
One Fin Capital Management LP704K0.65%US$11.5MSep 30, 2026
Two Sigma696K0.64%US$11.3MSep 30, 2026
Northern Trust626K0.58%US$10.2MSep 30, 2026
Schwab617K0.57%US$10MSep 30, 2026
Morgan Stanley616K0.57%US$10MSep 30, 2026
Healthcare Of Ontario Pension Plan Trust Fund605K0.56%US$9.85MSep 30, 2026
Adage Capital Partners Gp, L.L.C.568K0.52%US$9.25MSep 30, 2026
State Of Michigan Retirement System494K0.46%US$8.04MSep 30, 2026
TIG Advisors, LLC487K0.45%US$7.92MSep 30, 2026
LMR Partners LLP450K0.42%US$7.33MSep 30, 2026
Governors Lane LP421K0.39%US$6.86MSep 30, 2026
Jump Financial, LLC348K0.32%US$5.67MSep 30, 2026
Sumitomo Mitsui Trust Group, Inc.339K0.31%US$5.52MSep 30, 2026
Amova Asset Management Americas, Inc.339K0.31%US$5.51MSep 30, 2026
Howland Capital Management LLC327K0.30%US$5.33MSep 30, 2026
IQ EQ FUND MANAGEMENT (IRELAND) Ltd325K0.30%US$5.3MSep 30, 2026
Freshford Capital Management, LLC311K0.29%US$5.07MSep 30, 2026
Marshall Wace, LLP306K0.28%US$4.99MSep 30, 2026
XTX Topco Ltd295K0.27%US$4.81MSep 30, 2026
ExodusPoint Capital Management, LP284K0.26%US$4.62MSep 30, 2026
Susquehanna269K0.25%US$4.38MSep 30, 2026
Soros Fund Management LLC250K0.23%US$4.07MSep 30, 2026
Marble Bar Asset Management LLP241K0.22%US$3.92MSep 30, 2026
Perkins Capital Management Inc230K0.21%US$3.74MSep 30, 2026
Hrt Financial LP215K0.20%US$3.5MSep 30, 2026
Informed Momentum Co LLC206K0.19%US$3.36MSep 30, 2026

This page holds 50 of 186 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
ARK Genomic Revolution ETF6.73M6.2%US$85.3MJul 31, 2026
Vanguard Total Stock Market Index Fund2.14M2.0%US$28.7MJun 30, 2026
Columbia Small Cap Growth Fund1.87M1.7%US$21.4MMay 31, 2026
iShares Russell 2000 ETF1.73M1.6%US$23.2MJun 30, 2026
Columbia Acorn Fund1.28M1.2%US$17.1MJun 30, 2026
Vanguard Extended Market Index Fund796K0.73%US$10.7MJun 30, 2026
Fidelity Small Cap Index Fund743K0.69%US$9.41MJul 31, 2026
iShares Russell 2000 Value ETF618K0.57%US$8.28MJun 30, 2026
Nuveen Quant Small Cap Equity Fund570K0.53%US$7.22MJul 31, 2026
Strategic Advisers U.S. Total Stock Fund568K0.52%US$6.47MMay 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
iShares Biotechnology ETF437K0.40%US$5.86MJun 30, 2026
BlackRock Advantage Small Cap Core Fund360K0.33%US$4.1MMay 29, 2026
Dimensional U.S. Small Cap ETF340K0.31%US$4.3MJul 31, 2026
Fidelity Extended Market Index Fund279K0.26%US$3.18MMay 31, 2026
U.S. Small Cap Portfolio266K0.25%US$3.37MJul 31, 2026
Vanguard Russell 2000 Index Fund258K0.24%US$2.94MMay 31, 2026
Columbia Variable Portfolio - Acorn Fund248K0.23%US$3.32MJun 30, 2026
U.S. Micro Cap Portfolio239K0.22%US$3.02MJul 31, 2026
Bruce Fund233K0.21%US$3.12MJun 30, 2026
iShares Micro-Cap ETF221K0.20%US$2.97MJun 30, 2026
Schwab Small-Cap Index Fund164K0.15%US$2.08MJul 31, 2026
Dimensional U.S. Core Equity 2 ETF163K0.15%US$2.07MJul 31, 2026
Vanguard Health Care Index Fund158K0.15%US$1.81MMay 31, 2026
iShares Genomics Immunology and Healthcare ETF134K0.12%US$1.7MJul 31, 2026
Master Small Cap Index Series124K0.11%US$1.66MJun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF116K0.11%US$1.55MJun 30, 2026
Fidelity Total Market Index Fund103K0.10%US$1.18MMay 31, 2026
Fidelity Small Cap Value Index Fund95,0770.09%US$1.27MJun 30, 2026
Avantis U.S. Small Cap Equity ETF93,3850.09%US$1.06MMay 31, 2026
Nuveen Small Cap Blend Index Fund89,9060.08%US$1.14MJul 31, 2026
Amplify Etho Climate Leadership U.S. ETF85,5040.08%US$1.15MJun 30, 2026
Columbia Variable Portfolio - Small Company Growth Fund84,3780.08%US$1.13MJun 30, 2026
Fidelity Series Total Market Index Fund81,8520.08%US$933KMay 31, 2026
AlphaCentric Life Sciences and Healthcare Fund78,9240.07%US$1.06MJun 30, 2026
Nuveen Equity Index Fund75,6760.07%US$958KJul 31, 2026
EQ/2000 Managed Volatility Portfolio71,9550.07%US$964KJun 30, 2026
Fidelity Nasdaq Composite Index Fund61,9470.06%US$706KMay 31, 2026
U.S. Core Equity 1 Portfolio50,9180.05%US$645KJul 31, 2026
LVIP State Street Small-Cap Index Fund48,4000.04%US$649KJun 30, 2026
Schwab Total Stock Market Index Fund47,9410.04%US$607KJul 31, 2026
U.S. Core Equity 2 Portfolio44,3000.04%US$561KJul 31, 2026
Vanguard Russell 2000 Value Index Fund41,0820.04%US$468KMay 31, 2026
EQ/Small Company Index Portfolio40,2000.04%US$539KJun 30, 2026
Global X Genomics & Biotechnology ETF38,4750.04%US$439KMay 31, 2026
Fidelity ZERO Total Market Index Fund38,1660.04%US$483KJul 31, 2026
Vanguard Balanced Index Fund36,8910.03%US$494KJun 30, 2026
Vanguard Institutional Total Stock Market Index Fund35,0210.03%US$469KJun 30, 2026
Small Cap Index Fund34,2790.03%US$459KJun 30, 2026
BlackRock Advantage SMID Cap Fund, Inc.33,9300.03%US$455KJun 30, 2026
Global X Russell 2000 ETF32,4160.03%US$410KJul 31, 2026

This page holds 50 of 140 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Hall Christopher M
Director, Officer: Chief Executive Officer
Sale29,112USD 15.87US$462KNov 3, 2026
Tachibana Aaron
Officer: CFO AND COO
Sale2,931USD 16.22US$47,541Sep 18, 2026
Hall Christopher M
Director, Officer: Chief Executive Officer
Sale7,459USD 16.22US$121KSep 18, 2026
Chen Richard
Officer: President and CMO
Sale3,998USD 16.22US$64,848Sep 18, 2026
Moore Stephen Michael
Officer: SVP and Chief Legal Officer
Sale2,068USD 16.22US$33,543Sep 18, 2026
Chen Richard
Officer: President and CMO
Sale100,000USD 15.15US$1.51MJul 15, 2026
Hall Christopher M
Director, Officer: Chief Executive Officer
Sale100,000USD 15.08US$1.51MJul 9, 2026
Tachibana Aaron
Officer: CFO AND COO
Sale4,982USD 14.00US$69,748Jun 29, 2026
Tachibana Aaron
Officer: CFO AND COO
Sale51,251USD 13.18US$675KJun 26, 2026
Hall Christopher M
Director, Officer: Chief Executive Officer
Sale100,000USD 13.15US$1.31MJun 26, 2026
All 14 trades
TradeTradeSharesPriceValueDate
Tachibana Aaron
Officer: CFO AND COO
Sale40,000USD 12.01US$480KJun 4, 2026
Tachibana Aaron
Officer: CFO AND COO
Sale38,799USD 11.58US$449KMay 29, 2026
Hall Christopher M
Director, Officer: Chief Executive Officer
Sale80,091USD 11.02US$883KMay 29, 2026
Hall Christopher M
Director, Officer: Chief Executive Officer
Sale19,909USD 11.02US$219KMay 28, 2026

Big stakes

StakeStakeSharesDateFiling
Merck & Co., Inc.16.50%14MDec 19, 2024Schedule 13G
Eric Lefkofsky12.60%13.2MJul 19, 2026Schedule 13D
ARK Investment Management LLC6.67%7.12MSep 30, 2026Schedule 13G
BlackRock, Inc.5.90%6.17MJun 30, 2026Schedule 13G
Lightspeed Venture Partners Select IV, L.P.2.00%2.08MJun 8, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Karin Eastham
Other companies: Veracyte, Inc. (Board Member · Since at least Jun 20, 2016); Nektar Therapeutics (Director · Sep 27, 2018 – Sep 16, 2022 · Past); Geron Corporation (Director · May 17, 2016 – Jan 13, 2023 · Past); Illumina, Inc. (Director · May 17, 2016 – May 28, 2019 · Past)
Chair · Since at least Sep 9, 2019
Aaron Tachibana
Other companies: Lumentum Holdings Inc. (CFO · Jul 16, 2015 – Aug 18, 2018 · Past); Asyst Technologies Inc (SR. VP and CFO · May 31, 2007 – Nov 20, 2008 · Past)
Chief Financial Officer and Chief Operating Officer · Since at least Jun 19, 2019
Kenneth J. Widder
Other companies: QuidelOrtho Corporation (Director · Since at least May 27, 2022); Evoke Pharma Inc (Director · Since at least Sep 24, 2013)
Director · Since at least Jun 13, 2023
Patrick Balthrop
Other companies: MaxCyte, Inc. (Non-Executive Director · Since at least Nov 30, 2022); Oxford Immunotec Global PLC (Director · Jan 29, 2016 – Mar 8, 2021 · Past)
Director · Jun 19, 2019 – May 15, 2020 · Past
Christopher Hall
Other companies: Veracyte, Inc. (President and COO · Jul 22, 2015 – Jun 3, 2019 · Past)
Director · Since at least Dec 31, 2022
Olivia Bloom
Other companies: Geron Corporation (EVP, Chief Financial Officer · Feb 8, 2023 – Aug 15, 2023 · Past)
Director · Since at least May 17, 2022
Woodrow A Myers Jr
Other companies: Mallinckrodt Inc (Director · Jun 16, 2022 – Nov 14, 2023 · Past)
Director · Since at least Mar 6, 2021
A. Blaine BowmanDirector · Since at least May 12, 2026
Ashish KheterpalSenior Vice President, Chief Information Officer · Since at least Nov 5, 2026
Caroline CornerInvestor Relations · Since at least May 13, 2026
All 18 people
PersonSeat
Christian HaudenschildSenior Vice President, Genomic Science · Since at least Nov 5, 2026
Deepshikha BhandariSenior Vice President, Regulatory, Quality & Clinical Compliance · Since at least Nov 5, 2026
Jonathan MacQuittyDirector · Jun 19, 2019 – May 14, 2021 · Past
Lonnie ShoffDirector · Since at least May 17, 2024
Richard ChenPresident and Chief Medical Officer · Since at least Jun 19, 2019
Stephane MouradianSenior Vice President, Business Development · Since at least Nov 5, 2026
Stephen MooreSenior Vice President, Chief Legal Officer · Since at least Feb 17, 2022
Woodrow A. MyersDirector · Since at least May 14, 2026

Open People

Log in to ask 6ix AI your own questions about Personalis, Inc.